On September 27, 2021 Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, reported that Gritstone management will present webcasted company overviews at two upcoming investor conferences in September (Press release, Gritstone Oncology, SEP 7, 2021, View Source [SID1234592011]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference: H.C. Wainwright 23rd Annual Global Investment Conference
Date and Time: Monday, September 13, 2021 at 7:00 a.m. ET
Presenter: Andrew Allen, M.D., Ph.D., co-founder, president and chief executive officer

Conference: Cantor Virtual Global Healthcare Conference
Date and Time: Wednesday, September 29, 2021 at 2:40 p.m. ET
Presenter: Celia Economides, executive vice president and chief financial officer

A live webcast of the presentations will be accessible via the Investors & Media section of the company’s website at View Source An archived replay will be accessible for 30 days following each event.